Cargando…
PPAR-γ Activation Alleviates Osteoarthritis through Both the Nrf2/NLRP3 and PGC-1α/Δψ(m) Pathways by Inhibiting Pyroptosis
Osteoarthritis (OA) is a common degenerative joint disease with a gradually increasing morbidity in the aging and obese population. Emerging evidence has implicated pyroptosis in the etiology of OA and it may be recognized as a therapeutic target in OA. We have previously reported regarding another...
Autores principales: | Feng, Zhencheng, Huang, Qiuxiang, Zhang, Xingliang, Xu, Pengfei, Li, Siming, Ma, Dongli, Meng, Qingqi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070030/ https://www.ncbi.nlm.nih.gov/pubmed/37020714 http://dx.doi.org/10.1155/2023/2523536 |
Ejemplares similares
-
PPARγ Alleviates Sepsis-Induced Liver Injury by Inhibiting Hepatocyte Pyroptosis via Inhibition of the ROS/TXNIP/NLRP3 Signaling Pathway
por: Li, Zeyu, et al.
Publicado: (2022) -
Rosiglitazone ameliorates radiation-induced intestinal inflammation in rats by inhibiting NLRP3 inflammasome and TNF-α production
por: Hu, Liqiong, et al.
Publicado: (2020) -
PPARγ and PGC-1α as Therapeutic Targets in Parkinson’s
por: Corona, Juan Carlos, et al.
Publicado: (2014) -
PPARγ activation suppresses chondrocyte ferroptosis through mitophagy in osteoarthritis
por: Xue, Xiang, et al.
Publicado: (2023) -
PMI: A ΔΨ(m) Independent Pharmacological Regulator of Mitophagy
por: East, Daniel A., et al.
Publicado: (2014)